<DOC>
	<DOC>NCT01464840</DOC>
	<brief_summary>PKAZ is a single institution study designed to evaluate the optimal dosing parameters for azithromycin for pre-surgical cesarean prophylaxis. Hypothesis: Pre-operative administration of azithromycin results in maternal and neonatal tissue concentrations that adequately treat microbes commonly involved in post-cesarean infections.</brief_summary>
	<brief_title>The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery</brief_title>
	<detailed_description />
	<mesh_term>Endometritis</mesh_term>
	<criteria>Women 19 years and older Term (37 weeks and greater) Singleton gestation Scheduled cesarean section Nonlaboring Intact membranes &lt; 19 years of age Preterm (&lt; 37 weeks) Multifetal gestation Laboring or ruptured membranes Known fetal anomaly Oligo or polyhydramnios Macrolide allergy Macrolide exposure within 2 weeks Medical comorbidities Hepatic or renal impairment Taking medications that prolong the QT interval Currently taking nelfinavir, efavirenz, or flucanozole Structural heart defects or arrythmia</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Pregnancy</keyword>
	<keyword>Cesarean section</keyword>
	<keyword>Antibiotic</keyword>
</DOC>